ABSTRACT
Background COVID-19 is transmitting worldwide drastically and infected nearly two and half million of people so far. Till date 2144 cases of COVID-19 is confirmed in Bangladesh till 18th April though the stage-3/4 transmission is not validated yet.
Methods To project the final infection numbers in Bangladesh we used the SIR mathematical model. Confirmed cases of infection data were obtained from Institute of Epidemiology, Disease Control and Research (IEDCR) of Bangladesh
Results The confirmed cases in Bangladesh follow our SIR model prediction cases. By the end of April the predicted cases of infection will be 17450 to 21616 depending on the control strategies. Due to large population and socio-economic characteristics, we assumed 60% social distancing and lockdown can be possible. Assuming that, the predicated final size of infections will be 3782558 on the 92th day from the first infections and steadily decrease to zero infection after 193 days
Conclusion To estimate the impact of social distancing we assumed eight different scenarios, the predicted results confirmed the positive impact of this type of control strategies suggesting that by strict social distancing and lockdown, COVID-19 infection can be under control and then the infection cases will steadily decrease down to zero.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study has not yet received any funds from any institute, organizations or government.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data in this study were obtained from publicly available sources.
